Kite Pharma Reports Full-Year and Fourth Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Kite Pharma (KITE) Q4 Report Illustrates 'Clear Vision', Stifel Says
March 26, 2015 4:54 PM EDTStifel analyst Thomas Shrader reiterated a Buy rating and $83 price target on Kite Pharma (NASDAQ: KITE) following Q4 results, saying the company's action "speak loud and clear"
Shrader commented, "Kite reported 4Q14 results this morning and summarized the years results. The... More
Kite Pharma (KITE) Tops Q4 EPS by 1c
March 26, 2015 8:02 AM EDTKite Pharma (NASDAQ: KITE) reported Q4 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
... More